β Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ’ Press Releases
Date | Press release |
---|---|
2025-04-25 09:00:00 | Tompkins Financial Corporation Reports Cash Dividend Ithaca, n.y.--(business wire)--tompkins financial corporation (nyse american:tmp) tompkins financial corporation announced today that its board of directors approved payment of a regular quarterly cash dividend of $0.62 per share, payable on may 16, 2025, to common shareholders of record on may 9, 2025. tompkins financial corporation is a banking and financial services company serving the central, western, and hudson valley regions of new york and the southeastern region of pennsylvania. headqu. |
2025-03-24 20:05:00 | Nxera Pharmaβs Partner Tempero Bio Initiates Phase 2 Trial With Tmp-301 For Alcohol Use Disorder Tokyo, japan and cambridge, uk, 25 march 2025 β nxera pharma co., ltd. (βnxeraβ or βthe companyβ; tse 4565) announces that its partner tempero bio, inc. has initiated a phase 2 trial of tmp-301, a potent, selective and orally available mglur5 negative allosteric modulator (nam), for the treatment of alcohol use disorder (clinical trial id: nct06648655). the full announcement from tempero bio can be found by clicking here, in which tempero bio also announces the close of a $70 million financing, the proceeds of which will be used to advance tmp-301 through the phase 2 trial for alcohol use disorder and a second phase 2 trial in cocaine use disorder planned to start over the next year. the funds will also be used by tempero bio to conduct phase 3-enabling activities for tmp-301 and preclinical studies for additional indications and formulations. |
2025-01-31 09:00:00 | Tompkins Financial Corporation Reports Cash Dividend Ithaca, n.y.--(business wire)--tompkins financial corporation (nyse american:tmp) tompkins financial corporation announced today that its board of directors approved payment of a regular quarterly cash dividend of $0.62 per share, payable on february 21, 2025, to common shareholders of record on february 14, 2025. tompkins financial corporation is a banking and financial services company serving the central, western, and hudson valley regions of new york and the southeastern region of pennsylva. |
2024-10-25 09:00:00 | Tompkins Financial Corporation Reports Increased Cash Dividend Ithaca, n.y.--(business wire)--tompkins financial corporation (nyse american:tmp) tompkins financial corporation announced today that its board of directors approved payment of a regular quarterly cash dividend of $0.62 per share, payable on november 15, 2024, to common shareholders of record on november 8, 2024. the dividend amount represents an increase of $0.01 per share, or 1.6% over the dividend paid in the third quarter of 2024, and an increase of $0.02 per share, or 3.3% over the dividen. |
2024-04-26 09:00:00 | Tompkins Financial Corporation Reports Cash Dividend Ithaca, n.y.--(business wire)--tompkins financial corporation (nyse american:tmp) tompkins financial corporation announced today that its board of directors approved payment of a regular quarterly cash dividend of $0.61 per share, payable on may 17, 2024, to common shareholders of record on may 10, 2024. the dividend amount represents an increase of $0.01 per share, or 1.6% over the dividend paid in the second quarter of 2023. tompkins financial corporation is a banking and financial services c. |
2024-01-26 09:00:00 |
|
2023-10-27 09:00:00 |
|
2023-07-21 09:00:00 |
|

π° Browse additional press releases for Tompkins Financial Corp!
Sign up for free or log inβ‘ Instantly access "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!